• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivanza Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4834.0
  • ISIN : INE984E01035
2.07 0 (1.47%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    2.04
  • Today’s High

    2.10
  • Open

    2.08
  • Perv Close

    2.04
  • 52W Low

    1.90
  • 52W High

    4.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    8.28

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.01

  • Debt-Equity Ratio

    1.47

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.51

  • Mar.Cap (₹Cr.)

    8.28

  • RONW (%)

    12.60

  • ROCE (%)

    10.23

Score Board

  • Equity (₹ in Cr.)

    4.00

  • BV (₹)

    1.00

  • Sales( ₹ in Cr.)

    2.94

  • NP (in Cr.)

    -0.70

  • NP Var(%)

    -319.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -0.20

  • Traded Value (₹ in Lakhs)

    8.28

  • 52 Week High

    4.90

  • 52 Week Low

    1.90

  • Price BSE

    2.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    8.28

  • P/C Ratio

    -11.70

  • P/E Ratio

    -11.50

  • Price Vs.BV

    -0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 14.41 14.21 9.15 9.22 9.43 2.22
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 14.41 14.21 9.15 9.22 9.43 2.22
Other Income 0.05 0.39 0.83 0.50 0.53 0.00
Stock Adjustments 0.19 -0.62 1.83 -0.46 -1.06 -0.37
Total Income 14.65 13.98 11.81 9.26 8.90 1.85
EXPENDITURE :            
Raw Materials 13.17 12.34 10.31 8.11 8.08 1.61
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.31 0.22 0.08 0.11 0.10 0.02
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.02 0.00
Selling and Administration Expenses 0.26 0.21 0.34 0.35 0.42 0.24
Miscellaneous Expenses 0.06 0.09 0.17 0.07 0.06 0.01
Employee Benefit Expenses 0.31 0.22 0.08 0.11 0.10 0.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 13.79 12.86 10.90 8.64 8.67 1.88
Operating Profit 0.86 1.12 0.90 0.63 0.24 -0.03
Interest 0.42 0.43 0.43 0.47 0.44 0.42
Gross Profit 0.44 0.69 0.47 0.16 -0.20 -0.45
Depreciation 0.01 0.00 0.01 0.01 0.00 0.00
Profit Before Tax 0.43 0.69 0.46 0.15 -0.20 -0.45
Current Tax 0.11 0.12 0.00 0.05 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.32 0.57 0.46 0.10 -0.20 -0.45
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.32 0.57 0.46 0.10 -0.20 -0.45
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.40 -0.17 -0.63 -0.73 -0.53 -0.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.72 0.40 -0.17 -0.63 -0.73 -0.53
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.08 0.14 1.16 0.25 -0.51 0.00
Earnings Per Share(Adj)-Unit Curr 0.08 0.14 0.12 0.03 - -
Book Value 1.18 1.10 9.57 8.41 8.16 8.67
Book Value(Adj)-Unit Curr 1.18 1.10 0.96 0.84 - -

Shareholding Pattern

  • Promoter Group

    20.02%

  • Public Share Holding

    79.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,007,833 20.02 8,007,833 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,007,833 20.02 8,007,833 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 200 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 600 0.00 200 2
2] Non Institution
Bodies Corporate 1,601,239 4.00 1,597,689 19
Clearing Members 35,325 0.09 35,325 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 355,052 0.89 349,952 58
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 634,992 1.59 634,992 75
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,360,421 5.90 2,360,421 7
Individuals holding nominal share capital up to Rs. 1 lakh 26,982,026 67.46 25,468,136 20,284
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 12,000 0.03 12,000 3
Sub Total 31,991,567 79.98 30,469,027 20,454
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 40,000,000 100.00 38,477,060 20,458

Company Background

Vivanza Biosciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivanza Biosciences Ltd
  • BSE Code : 4834.0
  • ISIN : INE984E01035
  • Incorporation Year

    1982

  • Registered Office

    403 Sarthik 2 Opp Rajpath Club
    S G Highway, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-07405699869

  • FAX

  • Chairman

  • Managing Director

    Jayendra Mehta

  • Company Secretary

  • Auditor

    Shivam Soni & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Vivanza Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivanza Biosci. 2.07 14.47 14.41 -12.18 8.98
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10